FMS | Pain | Psychopharmacology

The Psychopharmacology Advisory Board brings together experts in psychiatry, psychopharmacology, and the pathophysiology of mood disorders to work with the FMS Advisory Board on a multidisciplinary approach to FMS treatment and diagnosis. The Board’s primary responsibility is assisting us in selecting and evaluating the potential effectiveness of drug candidates and designing clinical trials for these compounds.

Charles Nemeroff, M.D., Ph.D. – Chairman
Reunette W. Harris Professor and Chairman
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine

Dr. Nemeroff has been the Reunette W. Harris Professor and Chairman of the Department of Psychiatry and Behavioral Sciences at the Emory University School of Medicine in Atlanta, Georgia since 1991. He serves on the Mental Health Advisory Council of the National Institute of Mental Health and the Biomedical Research Council for NASA. Dr. Nemeroff is the President of the American College of Psychiatrists and the past President of the American College of Neuropsychopharmacology. He serves as the Editor-in-Chief of the Psychopharmacology Bulletin, Associate Editor of Biological Psychiatry and is the Co-Editor-in-Chief of both Critical Reviews in Neurobiology and Depression and Anxiety. Dr. Nemeroff serves on the scientific advisory board of numerous pharmaceutical companies including Acadia Pharmaceuticals, Astra Pharmaceuticals, Forest Laboratories, Janssen, Organon, Glaxo SmithKline Beecham and Wyeth-Ayerst. Dr. Nemeroff has received numerous awards for his research including the Bowis Award from the American College of Psychiatrists and the Menninger Prize from the American College of Physicians.

Other Psychopharmacology Advisory Board members include:

David Dunner, M.D.
Director, Center for Anxiety & Depression
Professor, Department of Psychiatry and Behavioral Sciences
University of Washington

Martin Keller, M.D.
Professor and Chairman of Psychiatry and Human Behavior
Brown University School of Medicine

Lorrin M. Koran, M.D.
Department of Psychiatry and Behavioral Sciences
Stanford Medical Center

K. Ranga Krishnan, M.B., Ch.B.
Department of Psychiatry and Behavioral Sciences
Duke University

Stephen Stahl, M.D., Ph.D.
Department of Psychiatry
University of California at San Diego